您的位置: 首页 > 农业专利 > 详情页

EVALUATION DE LA RECOMBINAISON INDUITE PAR CRISPR/CAS AVEC UN ACIDE NUCLEIQUE DONNEUR EXOGENE IN VIVO
专利权人:
INC.;REGENERON PHARMACEUTICALS
发明人:
GONG, GUOCHUN,HUNT, CHARLEEN,HARTFORD, SUZANNE,ROJAS, JOSE,FRENDEWEY, DAVID,ZAMBROWICZ, BRIAN,MURPHY, ANDREW J.
申请号:
CA3065579
公开号:
CA3065579A1
申请日:
2018.07.31
申请国别(地区):
CA
年份:
2019
代理人:
摘要:
Methods and compositions are provided for assessing CRISPR/Cas-induced recombination of a target genomic locus with an exogenous donor nucleic acid in vivo or ex vivo. The methods and compositions employ non-human animals comprising a CRISPR reporter such as a genomically integrated CRISPR reporter for detecting and measuring CRISPR/Cas-induced repair of a coding sequence for a catalytically inactive reporter protein through recombination with an exogenous donor nucleic acid. Methods and compositions are also provided for making and using these non-human animals.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充